Malta - English - Medicines Authority

abbvie limited citywest business campus, dublin 24, ireland - solution for injection - deoxycholic acid 10 mg/ml - other dermatological preparations

New Zealand - English - Medsafe (Medicines Safety Authority)

abbvie limited - leuprorelin acetate 30mg (powder for injection compartment) - injection (depot) - 30 mg - active: leuprorelin acetate 30mg (powder for injection compartment) excipient: carmellose sodium glacial acetic acid lactic acid mannitol polysorbate 80 water for injection - lucrin (leuprorelin acetate) is indicated · in metastatic prostate cancer · in locally advanced prostate cancer, as an alternative to surgical castration · as an adjuvant treatment to radiotherapy in patients with high-risk localized or locally advanced prostate cancer · as an adjuvant treatment to radical prostatectomy in patients with locally advanced prostate cancer at high risk of disease progression

New Zealand - English - Medsafe (Medicines Safety Authority)

abbvie limited - adalimumab 100 mg/ml;  ;  ;   - solution for injection - 40 mg/0.4ml - active: adalimumab 100 mg/ml       excipient: mannitol polysorbate 80 water for injection - uveitis humira is indicated for the treatment of non-infectious intermediate, posterior and panuveitis in adult patients who have had an inadequate response to corticosteroids, in patients in need of corticosteroid-sparing, or in whom corticosteroid treatment is inappropriate. humira is indicated for the treatment of paediatric chronic non-infectious anterior uveitis in patients from 2 years of age who have had an inadequate response to or are intolerant to conventional therapy, or in whom conventional therapy is inappropriate

New Zealand - English - Medsafe (Medicines Safety Authority)

abbvie limited - bovine lung lipids 25 mg/ml (total phospholipids); colfosceril palmitate 11 mg/ml - 15.5 mg/ml (disaturated phosphatidylcholine); palmitic acid 1.4 mg/ml - 3.5 mg/ml (free fatty acid); tripalmitin 0.5 mg/ml - 1.75 mg/ml (triglycerides) - intratracheal suspension - 25 mg/ml - active: bovine lung lipids 25 mg/ml (total phospholipids) colfosceril palmitate 11 mg/ml - 15.5 mg/ml (disaturated phosphatidylcholine) palmitic acid 1.4 mg/ml - 3.5 mg/ml (free fatty acid) tripalmitin 0.5 mg/ml - 1.75 mg/ml (triglycerides) excipient: sodium chloride water for injection - survanta is indicated for prevention and treatment ("rescue") of respiratory distress syndrome (rds) (hyaline membrane disease) in premature infants. survanta significantly reduces the incidence of rds, mortality due to rds and air leak complications.

New Zealand - English - Medsafe (Medicines Safety Authority)

abbvie limited - lopinavir 100mg; ritonavir 25mg ((pharmacokinetic enhancer)) - film coated tablet - 100mg/25mg - active: lopinavir 100mg ritonavir 25mg ((pharmacokinetic enhancer)) excipient: colloidal silicon dioxide copovidone opadry yellow 85f32450 sodium stearyl fumarate sorbitan laurate - kaletra is indicated for the treatment of hiv-1 infection, in combination with other antiretroviral agents in adults and children aged 2 years and older.

New Zealand - English - Medsafe (Medicines Safety Authority)

abbvie limited - lopinavir 200mg; ritonavir 50mg ((pharmacokinetic enhancer)) - film coated tablet - 200mg/50mg. - active: lopinavir 200mg ritonavir 50mg ((pharmacokinetic enhancer)) excipient: colloidal silicon dioxide   hyprolose hypromellose copovidone, k value 28 iron oxide yellow macrogol 3350 macrogol 400 polysorbate 80 purified talc sodium stearyl fumarate sorbitan laurate titanium dioxide - kaletra is indicated for the treatment of hiv-1 infection, in combination with other antiretroviral agents in adults and children aged 2 years and older.

New Zealand - English - Medsafe (Medicines Safety Authority)

abbvie limited - lopinavir 80 mg/ml; ritonavir 20 mg/ml ((pharmacokinetic enhancer)) - oral solution - active: lopinavir 80 mg/ml ritonavir 20 mg/ml ((pharmacokinetic enhancer)) excipient: acesulfame potassium ammonium glycyrrhizinate castor oil citric acid ethanol vanilla, natural and artifical 33869 cotton candy, artificial 30-92-0011 glycerol high fructose corn syrup levomenthol peppermint oil povidone propylene glycol purified water saccharin sodium sodium chloride sodium citrate dihydrate - kaletra is indicated for the treatment of hiv-1 infection, in combination with other antiretroviral agents in adults and children aged 2 years and older.

Australia - English - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - dasabuvir,ombitasvir,paritaprevir,ribavirin,ritonavir -

Australia - English - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - dasabuvir sodium monohydrate,ombitasvir,paritaprevir,ribavirin,ritonavir -

Australia - English - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - dasabuvir sodium monohydrate,ombitasvir,paritaprevir,ritonavir -